# CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction

> **NCT06258447** · NA · RECRUITING · sponsor: **BioCardia, Inc.** · enrollment: 250 (estimated)

## Conditions studied

- Ischemic Heart Failure

## Interventions

- **DEVICE:** Autologous bone marrow mononuclear cells processed / delivered using the CardiAMP cell therapy system

## Key facts

- **NCT ID:** NCT06258447
- **Lead sponsor:** BioCardia, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2027-04-01
- **Final completion:** 2029-04-01
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06258447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06258447, "CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06258447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*